ARTICANZ - Beta (ver 0.91)

Annotated Registry of Trials in Cancer, Australia and New Zealand Ed. - Results - target/ALK

Search results

target/ALK
10 trial(s) found.
NCT06834074
NCT06765109
NCT06707610
NCT06656390
NCT05384626
NCT04774718
NCT04094610
NCT03947385
NCT03093116
ACTRN12621000991819
Not Applicable
Filters
ALK
80%
ROS1
50%
RET
20%
TRK
20%
MET
20%
FGFR2
10%
FGFR2b
10%
MEK
10%
PKC
10%
ATR
10%
BCR-ABL1
10%
CDK4
10%
CDK6
10%
CRAF
10%
EGFR
10%
FLT3
10%
JAK1
10%
JAK2
10%
KIT
10%
PDGFR
10%
PDGFRA
10%
PI3K
10%
RAF
10%
SMO
10%
SRC
10%
VEGFR
10%
YES1
10%
mTOR
10%
mTORC1
10%
mTORC2
10%




















 






























	
		
	

    

        

			ARTICANZ (Annotated Registry of Trials in Cancer, Australia/NZ Edition; ARTificial Intelligence-enhanced CANcer trial information database) provides information about cancer drug trials in Australia and New Zealand as a free, open-information platform. Please note the following:

			
    
			
  • Data Accuracy: While ARTICANZ strives to maintain accurate and up-to-date information through regular weekly updates and specialist review, we cannot guarantee the complete accuracy, reliability, or timeliness of all data. Information may change between updates.
    • 
			
			
  • Not Medical Advice: The information provided by ARTICANZ is for informational purposes only and should not be considered medical advice. All clinical decisions should be made in consultation with qualified healthcare professionals.
    • 
			
			
  • No Warranty: ARTICANZ is provided "as is" without any warranties, expressed or implied. We disclaim all liability for any damages arising from the use of or inability to use this platform.
    • 
			
			
  • External Links: ARTICANZ may contain links to external websites. We are not responsible for the content or privacy practices of these sites.
    • 
			
			


			By using ARTICANZ, you acknowledge that you have read and understood this disclaimer.
			
		

        

            
The ARTICANZ platform and its contents are made available under the Creative Commons Attribution 4.0 International License (CC BY 4.0).

            
            
Users are free to:

            
    
                
  • Share — copy and redistribute the data in any medium or format
    • 
                
  • Adapt — remix, transform, and build upon the data
    • 
                
  • Use the data for any purpose, including commercial use
    • 
            

            
            
Under the following terms:

            
    
                
  • Attribution — You must give appropriate credit to ARTICANZ, provide a link to the license, and indicate if changes were made
    • 
                
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits
    • 
            

            
            
Platform developed and currently maintained by Dr. Frank Lin and the ARTICANZ team.